News | May 02, 2022
Dr. Mansukh Mandaviya to chair a three-day health meet at Kevadia in Gujarat
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Subscribe To Our Newsletter & Stay Updated
